• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发用于B型利钠肽(BNP)≥100 pg/ml水平的风险评分:须田研究

Developing a risk score for B-type natriuretic peptide (BNP) ≥ 100 pg/ml levels: the suita study.

作者信息

Arafa Ahmed, Kato Yuka, Matsumoto Chisa, Khairan Paramita, Maeda Saori, Kokubo Yoshihiro

机构信息

Department of Preventive Cardiology, National Cerebral and Cardiovascular Center, 6-1, Kishibe-Shinmachi, Suita, Osaka, 564-8565, Japan.

Department of Public Health, Faculty of Medicine, Beni-Suef University, Beni- Suef, Egypt.

出版信息

BMC Cardiovasc Disord. 2025 Sep 2;25(1):649. doi: 10.1186/s12872-025-05031-w.

DOI:10.1186/s12872-025-05031-w
PMID:40898037
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12403414/
Abstract

BACKGROUND

Increased plasma levels of B-type natriuretic peptide (BNP) serve as a biomarker for heart failure (HF). This study aimed to develop a risk score to predict elevated BNP levels using traditional cardiovascular disease (CVD) risk factors.

METHODS AND RESULTS

We analyzed data from 2809 Japanese individuals aged ≥ 40 years from the Suita Study, a population-based prospective cohort. All participants underwent follow-ups involving BNP measurements every two years. Developing BNP levels ≥ 100 pg/mL, a potential indicator of HF requiring treatment, was the outcome. Cox regression was applied to calculate hazard ratios for several CVD risk factors associated with developing BNP levels ≥ 100 pg/mL. Within a median follow-up period of 8 years, 339 participants developed BNP levels ≥ 100 pg/mL. The risk factors included older age, heavy smoking, former and heavy alcohol consumption, high blood pressure, estimated glomerular filtration rate < 45 mL/min/1.73 m, CVD history, cardiac murmur, arrhythmia including atrial fibrillation, and left ventricular hypertrophy. The prediction model performed well in terms of discrimination (C-statistics = 0.750) and calibration (p-value for goodness-of-fit > 0.150).

CONCLUSION

Our findings highlighted several CVD risk factors for BNP levels ≥ 100 pg/mL in the general Japanese population. Lifestyle modifications and regular health check-ups should be applied to reduce HF risk in vulnerable individuals.

摘要

背景

B型利钠肽(BNP)血浆水平升高是心力衰竭(HF)的生物标志物。本研究旨在利用传统心血管疾病(CVD)危险因素开发一种风险评分,以预测BNP水平升高。

方法与结果

我们分析了来自须惠研究的2809名年龄≥40岁的日本个体的数据,这是一项基于人群的前瞻性队列研究。所有参与者每两年接受一次随访,包括测量BNP。BNP水平≥100 pg/mL(这是需要治疗的HF的一个潜在指标)作为研究结果。采用Cox回归计算与BNP水平≥100 pg/mL相关的几种CVD危险因素的风险比。在中位随访期8年期间,339名参与者的BNP水平≥100 pg/mL。危险因素包括年龄较大、重度吸烟、既往和重度饮酒、高血压、估计肾小球滤过率<45 mL/min/1.73 m²、CVD病史、心脏杂音、包括心房颤动在内的心律失常以及左心室肥厚。该预测模型在区分度(C统计量=0.750)和校准(拟合优度p值>0.150)方面表现良好。

结论

我们的研究结果突出了日本普通人群中BNP水平≥100 pg/mL的几种CVD危险因素。应采取生活方式干预和定期健康检查,以降低易感个体发生HF的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5db9/12403414/46d3a66074d8/12872_2025_5031_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5db9/12403414/ee5fcbf6a531/12872_2025_5031_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5db9/12403414/46d3a66074d8/12872_2025_5031_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5db9/12403414/ee5fcbf6a531/12872_2025_5031_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5db9/12403414/46d3a66074d8/12872_2025_5031_Fig2_HTML.jpg

相似文献

1
Developing a risk score for B-type natriuretic peptide (BNP) ≥ 100 pg/ml levels: the suita study.开发用于B型利钠肽(BNP)≥100 pg/ml水平的风险评分:须田研究
BMC Cardiovasc Disord. 2025 Sep 2;25(1):649. doi: 10.1186/s12872-025-05031-w.
2
How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review.B型利钠肽对心力衰竭患者死亡和心脏事件的预测效果如何:系统评价
BMJ. 2005 Mar 19;330(7492):625. doi: 10.1136/bmj.330.7492.625.
3
Association between urinary sodium-to-potassium ratio and BNP in a general population without antihypertensive treatment and cardiovascular diseases: the Ohasama study.无抗高血压治疗及心血管疾病的普通人群中尿钠钾比值与脑钠肽的关联:大岛研究
Hypertens Res. 2025 Jun 27. doi: 10.1038/s41440-025-02266-0.
4
Atrial Natriuretic Peptide at Discharge as a Predictive Marker for Early Rehospitalization in Patients With Heart Failure With Preserved Ejection Fraction.射血分数保留的心力衰竭患者出院时的心房利钠肽作为早期再住院的预测标志物
J Am Heart Assoc. 2025 Aug 19;14(16):e040320. doi: 10.1161/JAHA.124.040320. Epub 2025 Aug 12.
5
Validation of N-Terminal Pro B-Type Natriuretic Peptide Threshold for Early Detection of Pre-Heart Failure in a General Japanese Population - Toon Health Study.N 端前体 B 型利钠肽阈值在日本普通人群中早期检测心力衰竭前期的验证——Toon 健康研究
Circ J. 2025 Jun 25;89(7):966-972. doi: 10.1253/circj.CJ-24-0774. Epub 2025 May 8.
6
Serum cholesterol levels and the risk of brain natriuretic peptide-diagnosed heart failure in postmenopausal women: a population-based prospective cohort study.绝经后妇女血清胆固醇水平与脑钠肽诊断心力衰竭的风险:一项基于人群的前瞻性队列研究。
Menopause. 2023 Aug 1;30(8):831-838. doi: 10.1097/GME.0000000000002215. Epub 2023 Jul 4.
7
Brain natriuretic peptide and N-terminal brain natriuretic peptide for the diagnosis of haemodynamically significant patent ductus arteriosus in preterm neonates.脑利钠肽和 N 末端脑利钠肽在诊断早产儿血液动力学意义未闭动脉导管中的应用。
Cochrane Database Syst Rev. 2022 Dec 8;12(12):CD013129. doi: 10.1002/14651858.CD013129.pub2.
8
Machine learning-based prediction of elevated N terminal pro brain natriuretic peptide among US general population.基于机器学习对美国普通人群中N末端脑钠肽前体升高情况的预测
ESC Heart Fail. 2025 Apr;12(2):859-868. doi: 10.1002/ehf2.15056. Epub 2024 Nov 19.
9
Cellular Adhesion Molecules and Adverse Outcomes in Chronic Heart Failure: Findings From the DAPA-HF Randomized Clinical Trial.细胞黏附分子与慢性心力衰竭的不良结局:来自DAPA-HF随机临床试验的结果
JAMA Cardiol. 2025 Jun 4. doi: 10.1001/jamacardio.2025.1592.
10
Diagnosing Acute Heart Failure in the Emergency Department: A Systematic Review and Meta-analysis.急诊科急性心力衰竭的诊断:一项系统评价与Meta分析
Acad Emerg Med. 2016 Mar;23(3):223-42. doi: 10.1111/acem.12878. Epub 2016 Feb 13.

本文引用的文献

1
Developing and Validating a New Atrial Fibrillation Risk Score Using Medical Examination Items in a Japanese Population - The Suita Study.利用日本人群的医学检查项目开发并验证一种新的房颤风险评分——吹田研究
Circ J. 2025 May 23;89(6):819-825. doi: 10.1253/circj.CJ-24-0939. Epub 2025 Mar 11.
2
Diagnostic accuracy of artificial intelligence in detecting left ventricular hypertrophy by electrocardiograph: a systematic review and meta-analysis.人工智能通过心电图检测左心室肥厚的诊断准确性:系统评价和荟萃分析。
Sci Rep. 2024 Jul 10;14(1):15882. doi: 10.1038/s41598-024-66247-y.
3
B-type natriuretic peptide levels predict long-term mortality in a large cohort of adults with congenital heart disease.
B 型利钠肽水平可预测大型先天性心脏病成年患者的长期死亡率。
Eur Heart J. 2024 Jun 14;45(23):2066-2075. doi: 10.1093/eurheartj/ehae254.
4
Obesity and cardiovascular health.肥胖与心血管健康。
Eur J Prev Cardiol. 2024 Jun 3;31(8):1026-1035. doi: 10.1093/eurjpc/zwae025.
5
Development of new scores for atherosclerotic cardiovascular disease using specific medical examination items: the Suita Study.利用特定体检项目开发动脉粥样硬化性心血管疾病新评分:Suita 研究。
Environ Health Prev Med. 2023;28:61. doi: 10.1265/ehpm.23-00099.
6
Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America.心力衰竭流行病学与结局统计:美国心力衰竭学会报告
J Card Fail. 2023 Oct;29(10):1412-1451. doi: 10.1016/j.cardfail.2023.07.006. Epub 2023 Sep 26.
7
Serum cholesterol levels and the risk of brain natriuretic peptide-diagnosed heart failure in postmenopausal women: a population-based prospective cohort study.绝经后妇女血清胆固醇水平与脑钠肽诊断心力衰竭的风险:一项基于人群的前瞻性队列研究。
Menopause. 2023 Aug 1;30(8):831-838. doi: 10.1097/GME.0000000000002215. Epub 2023 Jul 4.
8
Incidence and risks of coronary heart disease and heart failure in Japanese patients with type 2 diabetes mellitus: The Fukuoka diabetes registry.日本 2 型糖尿病患者冠心病和心力衰竭的发生率及风险:福冈糖尿病注册研究。
Diabetes Res Clin Pract. 2023 Jul;201:110732. doi: 10.1016/j.diabres.2023.110732. Epub 2023 May 26.
9
Alcohol consumption and the risk of heart failure: the Suita Study and meta-analysis of prospective cohort studies.饮酒与心力衰竭风险:Suita 研究和前瞻性队列研究的荟萃分析。
Environ Health Prev Med. 2023;28:26. doi: 10.1265/ehpm.22-00231.
10
Burden, Trends, and Inequalities of Heart Failure Globally, 1990 to 2019: A Secondary Analysis Based on the Global Burden of Disease 2019 Study.全球心力衰竭负担、趋势和不平等状况:基于 2019 年全球疾病负担研究的二次分析。
J Am Heart Assoc. 2023 Mar 21;12(6):e027852. doi: 10.1161/JAHA.122.027852. Epub 2023 Mar 9.